Cargando…

Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease

BACKGROUND: Effective SARS-CoV-2 vaccination in patients receiving treatment with B-cell depleting agents is challenging. Information on vaccination responses in these patients are a valuable tool to develop efficient vaccination regimens. METHODS: In this single-center retrospective observational s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnold, Frederic, Huzly, Daniela, Tanriver, Yakup, Welte, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472190/ https://www.ncbi.nlm.nih.gov/pubmed/36104663 http://dx.doi.org/10.1186/s12879-022-07722-7

Ejemplares similares

Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients – a case series with four patients
por: Schneider, Johanna, et al.
Publicado: (2023)

IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living‐donor kidney transplant: A case‐control study
por: Tanriver, Ursula, et al.
Publicado: (2022)

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
por: Weigang, Sebastian, et al.
Publicado: (2021)

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study
por: Arnold, Frederic, et al.
Publicado: (2020)

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Meyer, Thomas, et al.
Publicado: (2022)

Autoimmune phenomena following SARS-CoV-2 vaccination
por: Ishay, Yuval, et al.
Publicado: (2021)

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
por: Vuille-Lessard, Élise, et al.
Publicado: (2021)

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
por: Jaki, Lena, et al.
Publicado: (2023)

Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein
por: Matyushkina, Daria, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
por: Kang, Seong Hee, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA
por: Flower, Barnaby, et al.
Publicado: (2020)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing
por: Frasca, Daniela, et al.
Publicado: (2021)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
por: Cozzani, Emanuele, et al.
Publicado: (2021)

Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
por: Leon, Judith, et al.
Publicado: (2022)

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
por: Al‐Janabi, A., et al.
Publicado: (2021)

Association between immunosuppressants and poor antibody responses to inactivated SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

SARS-CoV-2, the autoimmune virus
por: Halpert, Gilad, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
por: Bowes, Cynthia L., et al.
Publicado: (2022)

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
por: Rocco, Alba, et al.
Publicado: (2021)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response
por: Huzly, Daniela, et al.
Publicado: (2022)

The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodies
por: Liu, Kexin, et al.
Publicado: (2022)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
por: Guiomar, Raquel, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

Factors Influencing Antibody Response to SARS-CoV-2 Vaccination
por: Kodde, Cathrin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hc0k8ranc60se3rmsqtpfg9fi8